Business Context and Reporting Period
This Form 8-K Current Report was filed by Cigna Corporation on May 28, 2021. The filing serves as a Regulation FD disclosure to inform investors and analysts of the Company's reaffirmed full-year 2021 financial outlook, which was previously discussed in a press release and investor presentation dated May 7, 2021.
Key Financial Metrics and Guidance
Cigna officials expect to reaffirm the following projected full-year 2021 consolidated adjusted metrics:
- Adjusted Revenues: At least $166 billion.
- Adjusted Income from Operations: At least $7.0 billion.
- Adjusted Income from Operations per Share: At least $20.20 per share.
- Weighted Average Shares Outstanding: Range of 346 million to 348 million.
The outlook includes approximately $1.25 per share in net unfavorable impacts of COVID-19, as well as the impact of future share repurchases and anticipated 2021 dividends. The filing does not provide specific GAAP revenue, profit, cash flow, debt, or liquidity figures for the current period, as this document focuses on forward-looking non-GAAP guidance.
Material Changes and Definitions
This filing reaffirms guidance previously issued on May 7, 2021, indicating no material change to the outlook at the time of this report. The Company defines "Adjusted Revenues" as total revenues excluding special items and Cigna's share of certain realized investment results of its joint ventures in the International Markets segment. "Adjusted Income from Operations" is defined as shareholders' net income excluding net realized investment results, amortization of acquired intangible assets, and special items. Management notes that a reconciliation to GAAP measures cannot be provided on a forward-looking basis due to the uncertainty of future investment results and special items.
Outlook, Risks, and Contingencies
Capital Allocation: Cigna intends to pay regular quarterly dividends, subject to Board approval. The Company also maintains a share repurchase program, the timing and volume of which depend on market conditions and capital requirements.
Risks and Uncertainties: The filing includes extensive cautionary statements regarding forward-looking information. Key risks include:
- The scale, scope, and duration of the COVID-19 pandemic.
- Price competition and margin compression.
- Actual claims exceeding estimates.
- Regulatory changes and government program participation (e.g., Medicare).
- Cybersecurity threats and data privacy incidents.
- Significant indebtedness and credit risk related to reinsurers.
Investor Verification Checklist
- Verify the specific definitions of "Adjusted Revenues" and "Adjusted Income from Operations" to understand exclusions from GAAP measures.
- Confirm the $1.25 per share net unfavorable COVID-19 impact included in the per-share guidance.
- Review the May 7, 2021 press release and investor presentation for the original context of the reaffirmed guidance.
- Monitor future Board decisions regarding quarterly dividend declarations and share repurchase execution.
- Assess the impact of the stated risks, particularly regarding medical claims and regulatory environments, on the ability to meet the $166 billion revenue target.